article thumbnail

The FDA Ramps Up GMP Inspections

Dot Compliance

Prior to the COVID-19 pandemic, during fiscal year (FY) 2019 (October 1, 2018, through September 30, 2019), the FDA conducted 7,266 GMP inspections of registered drug, device and biologics establishments. Compliance Dashboard, Inspections, FDA, accessed October 3, 2022, [link] cd/inspections.htm ).

FDA 52
article thumbnail

FDA Issues Draft Guidance on Labeling of Plant-Based Milk Alternatives

Health Law Advisor

Food and Drug Administration (“FDA”) announced a much-anticipated draft guidance regarding the naming and labeling of plant-based milk alternatives. [1] The dairy industry has lobbied both federal and state governments to restrict the use of “milk” to only fluid “obtained by the complete milking of one or more healthy cows.” [2]

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

Experts’ Views on FDA Regulatory Standards for Drug and High-Risk Medical Devices: Implications for Patient Care. A New Way to Contain Unaffordable Medication Costs – Exercising the Government’s Existing Rights. Medicaid Expenditures and Estimated Rebates on Line Extension Drugs, 2010-2018. 2022 Feb 24.

FDA 205
article thumbnail

What If Costco Designed the Prescription Drugs Sales Model?

Health Populi

Its longer more formal name was The Drug Price Competition and Patent Term Restoration Act of 1984, and it created a pathway for generic drug applications to the FDA. “Among the 184 most commonly prescribed drugs in Medicare Part D in 2018, 90% could be purchased at Costco for less than $20 for a 30-day supply.”

article thumbnail

U.S. Food and Drug Administration Issues Draft Guidance Updating Good Clinical Practices 

Hall Render

Food and Drug Administration (“FDA”) released draft guidance (“Draft Guidance”) updating Good Clinical Practices (“GCPs”) recommendations for interventional clinical trials involving human subjects. The last version of GCP guidance, known as E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1) , became effective in March 2018.

FDA 40
article thumbnail

Moving at the speed of Eugene Borukhovich, Bayer’s Global Head of Digital Health Innovation — Harlow On Healthcare

Health Blawg

Eugene and his team are just getting this off the ground (Summer 2018). Eugene and his team are just getting this off the ground (Summer 2018). Everyone loves change, but nobody wants to change.”. Join the conversation on Twitter at #HarlowOnHC. David Harlow. The Harlow Group LLC. Health Care Law and Consulting.

FDA 113
article thumbnail

CareCloud CEO predicts what's around the corner for telehealth

Healthcare IT News - Telehealth

We launched our first fully integrated telehealth solution in the 2018-2019 timeframe. As more and more wearable devices are becoming common in the technology, they have even started to get some FDA approvals as well. What were some of the changes you saw at CareCloud during the pandemic when it came to telehealth?

COVID-19 162